OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nonalcoholic Steatohepatitis After Liver Transplantation
Thomas G. Cotter, Michael Charlton
Liver Transplantation (2019) Vol. 26, Iss. 1, pp. 141-159
Closed Access | Times Cited: 74
Thomas G. Cotter, Michael Charlton
Liver Transplantation (2019) Vol. 26, Iss. 1, pp. 141-159
Closed Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
NAFLD and liver transplantation: Disease burden, current management and future challenges
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 177
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 177
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
Arun J. Sanyal, Patricia López, Eric Lawitz, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 392-400
Open Access | Times Cited: 100
Arun J. Sanyal, Patricia López, Eric Lawitz, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 392-400
Open Access | Times Cited: 100
Thyromimetics and MASLD: Unveiling the Novel Molecules Beyond Resmetirom
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Devaraj Ezhilarasan
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials
Takumi Kawaguchi, Michael Charlton, Atsushi Kawaguchi, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 03, pp. 225-234
Closed Access | Times Cited: 64
Takumi Kawaguchi, Michael Charlton, Atsushi Kawaguchi, et al.
Seminars in Liver Disease (2021) Vol. 41, Iss. 03, pp. 225-234
Closed Access | Times Cited: 64
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 638-650
Closed Access | Times Cited: 41
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 10, pp. 638-650
Closed Access | Times Cited: 41
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019
Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1168-1181
Open Access | Times Cited: 33
Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1168-1181
Open Access | Times Cited: 33
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Dong‐Sik Kim, Young‐In Yoon, Beom Kyung Kim, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 299-383
Open Access | Times Cited: 14
Dong‐Sik Kim, Young‐In Yoon, Beom Kyung Kim, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 299-383
Open Access | Times Cited: 14
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)
Thomas Berg, Niklas Aehling, Tony Bruns, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 09, pp. 1397-1573
Closed Access | Times Cited: 7
Thomas Berg, Niklas Aehling, Tony Bruns, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 09, pp. 1397-1573
Closed Access | Times Cited: 7
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S286-S301
Open Access | Times Cited: 29
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S286-S301
Open Access | Times Cited: 29
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 19
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 101-101
Open Access | Times Cited: 19
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
Paulina Głuszyńska, Dorota Lemancewicz, J Dzięcioł, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5721-5721
Open Access | Times Cited: 36
Paulina Głuszyńska, Dorota Lemancewicz, J Dzięcioł, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5721-5721
Open Access | Times Cited: 36
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity
Dong Cheng, Bradley A. Zinker, Yi Luo, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1732-1748.e5
Open Access | Times Cited: 24
Dong Cheng, Bradley A. Zinker, Yi Luo, et al.
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1732-1748.e5
Open Access | Times Cited: 24
Bariatric surgery, obesity and liver transplantation
Zunirah Ahmed, Muhammad Ali Khan, Luis Miguel Vazquez‐Montesino, et al.
Translational Gastroenterology and Hepatology (2022) Vol. 7, pp. 25-25
Open Access | Times Cited: 23
Zunirah Ahmed, Muhammad Ali Khan, Luis Miguel Vazquez‐Montesino, et al.
Translational Gastroenterology and Hepatology (2022) Vol. 7, pp. 25-25
Open Access | Times Cited: 23
Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159209-159209
Closed Access | Times Cited: 22
Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159209-159209
Closed Access | Times Cited: 22
Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 325, Iss. 1, pp. G42-G61
Open Access | Times Cited: 14
Benedikt Kaufmann, Nick Seyfried, Daniel Hartmann, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 325, Iss. 1, pp. G42-G61
Open Access | Times Cited: 14
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Zara Siu Wa Chui, Yaqian Xue, Aimin Xu
Medical Review (2024) Vol. 4, Iss. 2, pp. 158-168
Open Access | Times Cited: 4
Zara Siu Wa Chui, Yaqian Xue, Aimin Xu
Medical Review (2024) Vol. 4, Iss. 2, pp. 158-168
Open Access | Times Cited: 4
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 56-56
Open Access
Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 56-56
Open Access
Recurrent and De Novo Liver Disease After Liver Transplantation
Sally Condon, Cynthia Levy, Éric Martin
Clinics in Liver Disease (2025)
Closed Access
Sally Condon, Cynthia Levy, Éric Martin
Clinics in Liver Disease (2025)
Closed Access
Insights into Clinical Trials for Drugs Targeting MASLD : Progress, Challenges, and Future Directions
Yu Wu, Pu Dong, Q H Wu, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Yu Wu, Pu Dong, Q H Wu, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Exercise and Berberine Intervention Ameliorate High-Fat Diet-Induced MAFLD by Regulating Gut Microbiota and Hepatic Fatty Acid Beta-Oxidation
Xiaojian Zhang, Yanbin Cheng, Qingyu Wei, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2837-2854
Open Access
Xiaojian Zhang, Yanbin Cheng, Qingyu Wei, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2837-2854
Open Access
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
M. Hong Nguyen, Andrew Lian, Frederick T. Guilford, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 644-644
Open Access
M. Hong Nguyen, Andrew Lian, Frederick T. Guilford, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 644-644
Open Access
Impact of Education on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Southern Italy Cohort-Based Study
Rossella Donghia, Caterina Bonfiglio, Gianluigi Giannelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1950-1950
Open Access
Rossella Donghia, Caterina Bonfiglio, Gianluigi Giannelli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1950-1950
Open Access
Possible Role of Platelets in the Development and Progression of Non-Alcoholic Fatty Liver Disease
А.Ф. Шептулина, Ekaterina Liusina, Olga A. Zlobovskaya, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
А.Ф. Шептулина, Ekaterina Liusina, Olga A. Zlobovskaya, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis
Sakura Yamamura, Dan Nakano, Ryuki Hashida, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 3, pp. 629-636
Open Access | Times Cited: 34
Sakura Yamamura, Dan Nakano, Ryuki Hashida, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 3, pp. 629-636
Open Access | Times Cited: 34
